zelboraf
roche registration gmbh - vemurafenibas - melanoma - antinavikiniai vaistai - vemurafenibas yra skirtas monoterapijai, skirtai suaugusiems pacientams, sergantiems braf-v600-mutacija teigiama neužsikrečiama ar metastazavusia melanoma.
orfarin
orion corporation - varfarinas - tabletės - 3 mg; 5 mg - warfarin
raniberl
berlin-chemie ag (menarini group) - ranitidinas - plėvele dengtos tabletės - 150 mg; 300 mg - ranitidine
cladosol
stada arzneimittel ag - itrakonazolas - kietosios kapsulės - 100 mg - itraconazole
itraconazol actavis
teva b.v. - itrakonazolas - kietosios kapsulės - 100 mg - itraconazole
ranitidine siromed
ibe pharma, uab - ranitidinas - plėvele dengtos tabletės - 150 mg - ranitidine
tagrisso
astrazeneca ab - osimertinib mesilate - karcinoma, nesmulkiųjų ląstelių skausmas - kiti antinavikiniai vaistai agentai, baltymų kinazės inhibitoriai - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
onkotrone
baxter lithuania, uab - mitoksantronas - koncentratas infuziniam tirpalui - 2 mg/ml - mitoxantrone
quamatel
gedeon richter plc - famotidinas - plėvele dengtos tabletės - 20 mg; 40 mg - famotidine
ranigast
pharmaceutical works polpharma s.a. - ranitidinas - plėvele dengtos tabletės - 75 mg; 150 mg - ranitidine